Table 4 Complications after sedative administration
Variables | Outcome | Pre-weighted analysis | Post-weighted analysis | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
All cohort (n = 149) | Chloral hydrate group (n = 75) | Dexmedetomidine group (n = 74) | Statistic | p Value | All cohort (n = 298) | Chloral hydrate group (n = 150) | Dexmedetomidine group (n = 148) | Statistic | p Value | ||
Bradycardia (%) | |||||||||||
Falling asleep | Yes | 16 (11.4) | 4 (5.9) | 12 (16.4) | 3.9 | 0.0483 | 32 (11.4) | 9 (7.0) | 23 (15.4) | 5.02 | 0.0251 |
No | 125 (88.7) | 64 (94.1) | 61 (83.6) | 250 (88.6) | 126 (93.0) | 124 (84.6) | |||||
Total | 141 | 68 | 73 | 282 | 135 | 147 | |||||
Finishing TTE scan | Yes | 20 (15.0) | 5 (8.1) | 15 (21.1) | 4.42 | 0.0355 | 41 (15.3) | 12 (9.8) | 29 (20.1) | 5.49 | 0.0191 |
No | 113 (85.0) | 57 (91.9) | 56 (78.9) | 225 (84.7) | 112 (90.3) | 114 (79.9) | |||||
Total | 133 | 62 | 71 | 266 | 124 | 142 | |||||
Recovery at PACU | Yes | 3 (2.3) | 1 (1.6) | 2 (2.9) | 0.22 | 0.6421 | 7 (2.5) | 2 (1.8) | 4 (3.2) | 0.45 | 0.5027 |
No | 128 (97.7) | 60 (98.4) | 68 (97.1) | 255 (97.5) | 120 (98.2) | 135 (96.9) | |||||
Total | 131 | 61 | 70 | 262 | 122 | 140 | |||||
Oxygen desaturation (%) | |||||||||||
Falling asleep | Yes | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.00 | 1.00 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.00 | 1.00 |
No | 144 (100) | 70 (100) | 74 (100) | 282 (100) | 136 (100) | 146 (100) | |||||
Total | 144 | 70 | 74 | 282 | 136 | 146 | |||||
Finishing TTE scan | Yes | 3 (2.2) | 1 (1.6) | 2 (2.8) | 0.21 | 0.6495 | 6 (2.4) | 2 (1.4) | 5 (3.3) | 1.01 | 0.3150 |
No | 131 (97.8) | 61 (98.4) | 70 (97.2) | 261 (97.6) | 122 (98.6) | 139 (96.7) | |||||
Total | 134 | 62 | 72 | 268 | 124 | 144 | |||||
Recovery at PACU | Yes | 4 (3.0) | 3 (4.9) | 1 (1.4) | 1.34 | 0.2469 | 8 (2.9) | 6 (4.7) | 2 (1.4) | 2.40 | 0.1213 |
No | 127 (97.0) | 58 (95.1) | 69 (98.6) | 254 (97.1) | 116 (95.4) | 138 (98.6) | |||||
Total | 131 | 61 | 70 | 262 | 122 | 140 | |||||